admin

Author Archives

Rare diseases in the frames of the association

The association of citizens for rare diseases Life With Challenges, is founded by patients and parents that face with life with Gaucher. Later in the association joined patients with Hereditary Angioedema, Allagile Syndrome and

The association is representing patients and parents with rare diseases that are members in the association. At the moment there are over 80 diagnoses of rare diseases represented by the association: Gaucher, Phenylkeotnuria, Allagile Syndrome,  Tyrosinemia, Lenox Gastaut Syndrome, Congenital Muscular Distrophy, Muscular Dystrophy Duchene, Muscular Dystrophy Becker,  Congenital Cataract, Epydermolysis Bulosa, Carnitine plamitolitransferase deficiency, Pulmonary Hypertension, Adrenomyeloneuropathy, Williams Syndrome, RET Syndrome, Amyotropihi lateral sclerosis – Lou Gehrig’s diseases, Myasthenia Gravis , Huntington disease, Porphyria, malignant paraganglioma Pheochromocytoma  tumor, arthogryposis multiplex congenital, Fibrodysplasia ossificans progressiva (FOP), Multiple myeloma, Myelodysplastic syndrome, MPS 4 – Morqio Syndrome,   Strümpell disease – Hereditary spastic paraplegia, Takayasu arteritis, Primary ciliary dyskinesia, Kartagener type, Mastocytosis, Juvenile dermatomyositis, Friedreich ataxia , Acute intermittent porphyria, Cystinuria, Stargart, Lowe Syndrom, Dextocardia Situs inversus, Heurofibramatozis, Phemgus Vulgaris, Wegener’s Granulomatosis, Addison disease, Ehlers – Danhlos Syndrom, Alpha-1-antitrypsin deficiency, Aspergilosis, Erythrodermia Ichthyosiformis Congenital, Autosomal recessive dopa-responsive dystonia Tyrosine Hydroxylase deficiency, Alport Syndrom, Acute trasverse myelitis, Polimiozitis, Adrenogenital syndrome, Mastocitozis, Burgada Syndrom, Fanconi, Niemann Pick C, Chronic inflammatory demyelinating polyneuropathy, West Syndrome, Transverse Myelitis, Retinitis Pigmentosa,  Carney Complex,  Erythrodermia  Ichthyosiformis congenita, Guillain Barreov Sindrom, Malignant Melanoma, Rendu-Osler-Weber disease – hereditary hemorrhagic telangiectasia(HHT), Systemic vasculitis-Sy.Churg-Strauss, Spinal Muscular Atrophy, Barter Syndrome, FAP – Familial Amyloid Polyneuropathy, Pulmonary Fibrosis, Amelogenesis Imperfecta, Achondroplasia, Kabuki syndrome, Fibrin-stabilizing factor deficiency,  Hydromielia, Lyme disease, Julien Barre syndrome, Acure lymhoblastic leukemia, usher syndrome tip 2, chromosome 3p duplication, PFAPA syndrome, Raynaud syndrome, Familial mediterranean fever Hydromielia, Lyme disease, Julien Barre syndrome, Acure lymhoblastic leukemia, usher syndrome tip 2, chromosome 3p duplication, PFAPA syndrome, Raynaud syndrome, Familial mediterranean fever …  and others that will join us and ask for help and support.

Some groups of patients have their own associations and we encourage and support other groups to form associations since we think it is important for each disease to have association or at least a support group.

The association also is a member of the National Alliance for Rare Diseases of R. Macedonia (13 organizations representing different rare diseases and patients rights).  The association does not represent rare diseases that are not registered members in the association.

In Macedonia there are other diagnosed rare diseases. From 2015 there is a register for RD at the Ministry of Health – more about that can be found in the program for RD from 2016 –  Programa za lekuvanje na retki bolesti vo R.M. za 2016. (Translation in English will be available soon)


Register for rare diseases

What is a patient registry?

The term “Patient Registry” is defined as “a framework for collecting and analyzing data on a specific disease in order to cover the entire patient population in a country that is affected of that disease”.

Why is the rare disease registry important?

The rare disease registry is a census of diagnosed cases of rare diseases in a population.

The registration of rare diseases is a process of systematic collection and analysis of data on people with rare diseases, in order to provide a more accurate insight in the number of people suffering from rare diseases, and the number of rare diseases from which they are suffering.

Why is the rare disease registry useful?

The role of the registry is to enable:

  • Calculation of incidence of rare diseases by age, sex, place, diagnosis etc.
  • Continuous tracking of incidence over time
  • Analysis of survival rate of patients with rare diseases
  • Calculation of lost years of life, and years of life with disability
  • Determining direct and indirect cost of treating patients with rare diseases (caused by temporary or permanent disability or premature death)
  • This way of observing and monitoring patients with rare diseases is quite significant because it provides:
  • Expert approach in planning health management of rare diseases.
  • Development of a prevention program and preventive strategies (public information, health education, early detection, screening, reduction of complications in rare diseases)
  • Evaluation of implemented preventive measures
  • Formulation of a health policy and promotion of the organization of health care for patients with rare diseases
  • Assessment of the burden on society arising from rare diseases
  • An initial basis for epidemiological and clinical research

Some of the key benefits of a well-maintained registry would be:

  • The possibility of monitoring and improving the quality of care for patients with rare diseases;
  • Better implementation of a multidisciplinary approach to management of rare diseases;
  • Speeding up the daily clinical practice of healthcare workers and making clinical decisions;
  • Better planning of financial resources for the procurement of medicines for rare diseases;
  • Prevention planning and screening for rare diseases;
  • Monitoring the effectiveness of treatment for rare diseases;
  • More efficient use of health resources and
  • Providing a base for clinical research.

What is the current situation in Macedonia?

At this moment, there are no accurate statistics regarding data on rare diseases and the number of patients, but the registry for rare diseases began to develop in 2015, and patients are entered into the registry that is located at the Ministry of Health. There is also a special Program for Rare Diseases through which funds are allocated for the purchase of appropriate treatment for rare diseases, diagnosis (if diagnosing is not possible in Macedonia), and education of professional staff.

Prior to entering the data into the registry, it is taken and considered by an expert committee for rare diseases composed of health professionals from clinical centers (with a different field of expertise).

The exact financial implications of treating rare diseases cannot yet be examined.

Also, apart from the Ministry of Health, one part of the patients with rare diseases receives some of the necessary medicines, orthopedic aids, special nutrition, etc. from the Health Insurance Fund of Republic of North Macedonia. Another part of the patients with rare diseases receives medicines that are procured through the University Clinics in Skopje and are not registered in the register in the Ministry of Health. That is why it is necessary for the Ministry of Health to cooperate closely with the Health Insurance Fund, with the University Clinics, and with patient associations to ensure adequate care and treatment for patients with rare diseases.

In addition, cooperation with the Ministry of Labor and Social Policy is needed to implement appropriate measures of a social nature (appropriate assistance) so that patients with rare diseases are not excluded from social policy.

Certainly, the cooperation with health professionals and with the Macedonian Academy of Sciences and Arts, in terms of early diagnosis, appropriate information for patients and availability of early treatment is also important.

 

Why is it difficult to make this registry?

  • The natural course of many rare diseases is unknown, and many of them remain undiagnosed, therefore cannot be entered in the registry.
  • In the International Classification of Diseases, which is used for many diseases, there aren’t adequate codes. Because of that, many rare diseases remain unrecognized in the health care system.

What data is in the registry?

  • Data on the health facility where the diagnosis was made, or where the treatment for the rare disease is implemented
  • Data on the affected person (name, surname, social security number, date of birth, place of birth and place of residence, gender) in accordance of the law on protection of personal data
  • Data about the disease (appearance of symptoms, diagnosis, status, code, name of the disease)
  • Data on the clinical/laboratory findings (currently there is no such data in the registry)
  • Data on the treatment (whether there is a drug, name of the drug, treatment evaluation, primary, secondary, tertiary treatment, symptomatic treatment)
  • Data on the outcome of the disease (time and date of death)

What needs to be done as a priority?

  • To create an electronic version of the registry for rare diseases
  • To introduce new data items that will be collected in the registry
  • To enable easier access to analysis of data from the registry in anonymized form in order to create adequate policies based on facts to improve the quality of life of families with rare diseases
  • To enable the entry of data from family doctors, subspecialists and specialists who do not manage the patient, but monitor and consult about certain symptoms that result from the rare disease
  • To connect data from all health and social institutions where the patient’s illness is monitored and controlled (including physical therapy, psychologist, special education specialist, speech therapist, social assistance, disability assistance, etc.)
  • To further enable the input of data from patients (or their parent guardian) in order to collect and analyze data directly from patients regarding their physical and mental condition

Program for rare diseases of the Ministry of Health

The first program for rare diseases at the Ministry of health is from the year 2009 and it included 3 patients with MPS 2 – Hunter syndrome

Програма за ретки болести 2009 година – Program for 2009 in Macedonian language

There were no further changes until 2015 .

  1. Program for 2012  –   Програма за лекување на ретки болести во РМ за 2012 година – in Macedonian language
  2. Program for 2013  –   PROGRAMA ZA LEKUVAWE NA RETKI BOLESTI VO REPUBLIKA MAKEDONIJA ZA 2013 GODINA – in Macedonian language
  3. Program for 20126 –    Programa za lekuvanje na retki bolesti vo R.M. za 2016 – in Macedonian language

For the first time in 2016 there are finances for diagnosis and education.


Brochures

This document is a translation from the EURORDIS document – https://www.eurordis.org/publication/why-we-need-european-action-rare-disease 

This document is a translation from the EURORDIS document on Equity for rare diseases – https://download2.rarediseaseday.org/2020/Factsheet_Advocating%20for%20equity.pdf

This document is a translation from the EURORDIS position paper on newborn screening.  (https://download2.eurordis.org/documents/pdf/eurordis_nbs_position_paper.pdf ):

Informative brochure – LIFE WITH CHALLENGES – 2020 – Macedonian language


Regional cooperation

How did we start?

Our organization is founded with the help and support by the National Alliance of people with rare diseases of Bulgaria. The first meeting of families and doctors connected to rare diseases in Macedonia was organized by Bulgaria in Ohrid, Macedonia, in June, 2009.
Since than the patients in Macedonia decided to form their own organization and fight for their rights. This is how Life With Challenges was born.
In the next 3 years we were gathering members and learning how to manage and grow into a strong patient organization.
prv sostanok
Why cooperation?
  • Sharing knowledge in patient advocacy.
  • Sharing tools and best practices with patient organizations.
  • Learning how other organizations in the world accomplish their goals.
  • Getting support in policy development.
  • Getting support and new ideas for activities about raising public and institutional awareness about the problems and challenges of the patients and families.
  • Access to workshops, meetings, seminars and training on subjects important for development of strong patient advocates.
  • Access to new information of research and development of new medicines, new policies and new ways to help and support patients

Meetings for development of regional and international cooperation:

Second regional meeting of Gaucher patients and first regional meeting for lysosomal diseases  Sarajevo, Bosnia and Herzegovina,  5-7 April, 2013

saraevo

Second Balkan Conference for rare diseases – “Better communication – better treatment“, 20 – 22 April, 2013, Sofia, Bulgaria

bugarija

EURORDIS Membership Meeting, May, 2013, Dubrovnik, Croatia

dubrovnik

Patient Meeting Bulgaria – Macedonia, Skopje, 7 September, 2013

bg mk

Congress for rare diseases in South-East Europe, Skopje, Macedonia, 16 November, 2013

see

NORBS – National Plan Conference, Belgrade, Serbia, 5-7 December, 2013

norbs

DITA Task Force Meeting (Drug Information, Transparency and Access), London, UK, 8-10 December, 2013

dita

EUPATI – European patients academy on therapeutic innovation – 2014 – 2015

dita

European Federation of Neurological Associations training course on Pharmaceutical policy, pricing and reimbursement, at London Schools of Economics and political science, 13th to 14th of May, 2014, London, UK

london

EUnetHTA Training course and conference – HTA 2.0 Europe, Teaming up for value, 29th to 31st of October, 2014, Rome, Italy

hta

EURORDIS Membership meeting, 8th of May, 2014, Berlin, Germany

germanija eurordis

Bulgaria – Macedonia Meeting, Kustendil, Bulgaria, 1-3 May, 2015

bg kustendil

Partners for Progress: Patient advocacy in a changing environment, Lisbon, Portugal, 30 June – 1 July, 2015

ppf

The National Alliance for Rare Diseases of R. Macedonia – NARDM

12 organizations are founders of this alliance, in 2014 and we are open to new members that want to join our efforts in providing better quality of life for families that face life with a rare disease.
  • Our vision is providing best possible quality of life for people that face life with a rare disease.
  • Our mission is promoting the principles of equality, solidarity, non- discrimination, information and protection of rights of people with rare diseases in R. Macedonia and internationally.
  • Today NARDM has 13 organizations as members: Association of citizens for rare diseases LIFE WITH CHALLENGES, Bleeding disorder society of R. Macedonia – HEMOLOG, Association for Hereditary Angioedema – HAE Macedonia, Association for rare neurological diseases in children – Kokicnija, Association for hemophilia, Non Government Organization for Rheumatism and Arthritis – NORA, Association for Wilson Disease, Association for Emancipation, Solidarity and Equality of Women – ESE, Association for Pulmonary Hypertension – MOMENT PLUS, Association of citizens for Down Syndrome – Trisomy 21, Association for people with dysfunction, handicap, rare diseases and special needs – Dajte ni krilja, Macedonian Association for Chron and Ulcerative Colitis – MAKUK, Association of citizens for motivation and happier, more productive life of people with physical and mental disabilities – Nova Iskra.
narbm
EURORDIS Membership Meeting, Madrid, Spain, 29 – 30 May, 2015
inrare

European Gaucher Alliance Membership meeting, 28.06.-02.07.2016

The EGA is delighted to announce that during its Biennial General Meeting in Zaragoza on 29 June, its members expressed their wish to amend the founding constitution by abolishing the differentiation between full and associate membership. With a voting result of 69% in favour of providing full rights to non-European member associations, the majority of the members expressed their clear wish that the EGA becomes a global group.
On 29 June, Pascal Niemeyer was elected by the new board of the European Gaucher Alliance as chairman. Pascal has been working on the board since 2008 and is responsible for the areas of public relations and liaison with the EWGGD. Pascal takes over from Jeremy Manuel, who decided to step down as chairman to make way for the next generation, whilst assuring his dedication to continue to support the Gaucher community by agreeing to remain on the board.
The entire board would like to thank Jeremy for his tireless engagement in building and developing the EGA for more than 20 years.
The new board was formally announced as: Vesna Aleksovska (Macedonia), Biljana Jovanovic (Serbia), Anne-Grethe Lauridsen (Denmark), Jeremy Manuel (UK); Pascal Niemeyer, Chair (Germany), Johanna Parkkinen (Finland), Jasenka Wagner (Croatia), Sandra Zariņa (Latvia), Irena Žnidar (Slovenia).
Some very interesting discussions took place during the biennial meeting. Workshops where participants were split into four groups facilitated by board members. To inspire the discussion a short introduction was given on possible subjects to discuss, based on the information given in your Country Reports which were sent in ahead of the meeting.
The board has now evaluated all the written feedback from each groups and split the issues raised into the following 3 areas:

• How to get a diagnosis, switching treatment, treatment or no treatment, social aspects of GD
• Running an association; why and how
• Creating awareness towards different target groups
Looking deeper into the feedback, the overall theme identified was “Awareness” and so it was decided that a small group within the board should look at what this means on different levels. Based on this work the group will identify possible new projects to propose to the full board at the next meeting in January.


Skope Night Running RUNS for LIFE WITH CHALLENGES

The association of citizens for rare diseases LIFE WITH CHALLENGES continues with the tradition to participate on Skopje Marathon. This year the association Moment Plus from Gevgelija is also participating in the marathon.

On 8th of May, 2016, 60 participants from Skopje Night Running will run for Life With Challenges on 21 and 42 kilometers, and also there will be additional participants running for Moment Plus on 5 kilometers. The voice of rare diseases is stronger when we are together. 

13178925_1069770656429609_4124217537507643324_n

This activity is for raising public awareness about rare diseases in Macedonia, emphasizing the challenges that people with rare diseases and their families face in every day life. We are thankful to all that support us until today and we will continue with the cooperation further. We hope to contribute for a better future for people with rare diseases as an association. .

Statement – Vesna Aleksovska, President of Life With Challenges 

„Rare diseases are complex and to resolve the problems and the challenges that people with rare diseases face every day we all need to work together: the associations, the patients, the institutions, the health professionals, the pharmaceutical industry, researchers and other stakeholders … only with mutual work and good communication we can provide better quality of life. 

With the development of the register for rare diseases and the increase of the financial resources for procurement of medicines in the program for rare diseases, and also financial resources for diagnosis and education, the Ministry of Health made significant steps toward improving life of patients with rare diseases. We will continue with communication with the insitutions and hope to provide other benefits for the patients as procurement of special orthopedic devices and needed social services and care for patients that do not have available medicines at this point. Each patient deserves a chance for better life. Also I have to mention that rare cancers are still not taken care of, and the institutions need to make steps to care for these patients that at this point have no innovative medicines that are used in Europe and in our neighbor Balkan countries. “

 13177399_10154152222969481_7687087029989710792_n13220568_10154152222609481_9153772648007992231_o13139273_10154152223084481_6060689567271498273_n

Statement – Iskra Dimitar and Tomislav from Skopje Night Running Изјава – 

 Skopje Night Running as an initiative for raising awareness for recreational running is joining to support the fight for better quality of life for patients with rare diseases. Through our initiative for recreational running we supported different causes and it is our pleasure to give support to Life With Challenges for a second year in a row. 

Statement – Gjurgjica Kjaeva, President of Moment Plus – Association for pulmonary Hypertension 

„The World Day of Pulmonary Hyperteension is a gloabl campaign from the World association for PH for raising public awareness about his disease. PH is a diseases of the lungs and the heart. The World day of PH is being marked with events in whole Europe on 5th of May.  

Breath of Success is a campaign marking positive stories from patients that live with this disease and it is encouraging people to share their hopes and dreams. It is really important to get early diagnosis and early treatment. We hope that in future the patients in Macedonia will have more available medicines and better therapy so that they can have better quality of life.“

13177810_10154152222869481_3198177220374345690_n13178863_10154152222769481_5065532794254557022_n13173925_10154152222659481_2496213121008023663_n

The event is realized in cooperation with:

Skopje Night Running, Skopje Marathon

The event was supported from:

Genzyme – SAnofi Aventis, Celgene International, PH Europe


RARE DISEASE DAY 20.02.2016 Macedonia

On the occasion of the World Rare Disease Day 2016, the National Alliance of Rare Diseases of Macedonia organized an event to mark the occasion on 29 February (Modnay) in the cinema Frosina- MKC. In the course of the Friday, Saturday and Sunday prior to the 29th , events were as well organized in Ohrid, Prilep, Gevgelija and Bitola by handing out leaflets and activities such as hugging to break the Guinness record in hugging.

Ohrid: The Organisation of the Red Cross in Ohrid together with the Association for cycling, mounteneering and Eco-culture Z’s Avantura,  on the 27th under the title HUGGING OF GALICHICA organized a hiking tour on the mountain Galichica. The pupils from the State Secondary School “Sv Kliment Ohridski” marked the rare disease day by running an athletic cross race which took place on the 29.02.2016 at the Ohrid Lake Quay.

20160229_122135

Bitola: The association Hepar Centre organized handing out leaflets and hugging on 27.02.2016 (Saturday).

12806182_10153974520747188_611430155576340690_n

Gevgelija: The association Moment Plus organized hugging and handing out leaflets on 26.02.2016.

Prilep: Volunteers with the support of the Municipality of Prilep organized a fashion show in the cinema Miss Ston on the 27.02. 2016

 

Statements

The Managing Director of the Agency of Medicines and Medical Devices Ms. Marija Darkovska Serafimovska discussed the importance of ORPHA medicines. Although the rare diseases are few and generally the medicines necessary for them are not interesting for the pharmacological industry because the research they require is expensive and the market is small, lately there has been some positive advance as a result of sponsored research by the governments, shorter administrative procedure and the patent for these medicines lasts longer. In regard to these medicines in Macedonia in 2015 a continuous supply was provided and this was thanks to the amendments in the Law on Excise Tax and the work of the Rare Disease Commission. The Agency for Medicines and Medical Devices will continue to give its support in the same and similar way.

The Chairperson of the Commission for Rare Diseases PhD Aspazija Sofijanova, MD pointed out that living with a rare disease is a challenge; she also stated that it is an even greater challenge to maintain the disease under control. She emphasized that the rare disease registry is regularly updated and that we should all work together on greater integration of the people with rare disease in our society. She said she was grateful to everyone who is part of this struggle, as well as the media for the positive coverage of this issue. Ms. Sofijanova underlined that it is not only therapy that matters but also the family and the integration in society.

The MANU Representative, PhD Dijana Plasheska Karanfilska briefly stated how important is diagnostic and that although it is expensive it exists. Modern diagnostic tools are available to patients in Macedonia and with these tools prenatal and genetic diagnosis can be carried out, which help to determine the possibilities of a rare disease occurring in the family.

The President of the National Alliance of Rare Diseases, Vesna Aleksovska stated “At the beginning, in 2009, I was a lone fighter patient, but today we have a big family where we all fight the battle of Rare Diseases.” She summed up how important treatment was and pointed out the research that Life with Challenges carried out in cooperation with “Studiorum”.

Presentation of the research on rare diseases by Stefan Chichivaliev (Studiorum)

Stefan Chichivaliev discussed the road which a rare disease patient must take. This road begins with a diagnosis which can be very prompt or it can take longer. The second part of that road is actually the most important part which unifies the primary, secondary and tertiary health care and which helps the patient to maintain a stable stat with an appropriate treatment, which is actually the last part of the road. Without appropriate support the families fighting a rare disease face huge problems, foremost from an economical aspect as well as a social aspect.

12832452_1091588580861416_5104027358752965425_n

Additional information regarding the rare diseases in Macedonia:

Availability of medicines for rare diseases

According to the first two tenders through the rare disease programme of the Ministry of Health  can be seen that certain medicines are provided for the Gaucher disease, Hereditary Angiodem, Wilson’s Disease, Tuberous Sclerosis, Juvnenile Arthritis, Factor 13 Insuficiency, Huntington disease, Phenylketonuria, MPS 4 – Morkio Syndrome, MPS-2 Hunter Syndrome, Pulmonal Hypertension, Thyrosinemia , ALS- Lou Gehrig’s Syndrome, Cystic Fibrosis, etc. We hope that by registering patients in the registry within the Ministry of Health through the Commission for Rare Diseases other patients who face other diseases will also receive the necessary therapy. Certain medicines, orthopedic aid and special nutrition for rare diseases is also provided through the Health Insurance Fund of Republic of Macedonia (FZOM). Of course therapy in the form of medicine is not the only thing which is necessary, for many diseases it is necessary to provide a suitable orthopedic device, special nutrition, physical therapy, personal assistant, social inclusion or other social services that need to be provided through cooperation among institutions – The Ministry of Health, the Ministry of Labour and Social Policy , the Ministry of Education, MANU.

From the patients who have approached us as an Association asking for help and whom we have registered, it is necessary to provide additional medicines for the following diseases:

Myelodysplastc Syndrome, multiple myeloma, malign myeloma, additional medicines for pulmonary hypertension, medicines for Von Willebrand, supplement for Rett and Williams syndromes, bandages and plasters for epidermiosis bulosa, supplements for CPT deficiency, supplements for Lowe syndrome,  for cystinuria, then additional medicine for juvenile arthritis, additional medicines for Wilson’s disease, Chrone disease and ulcerous colitis (promised by FZOM), orthopedic aid for muscular dystrophy, cerebral palsy, additional physical therapy for arthogryposis multiple congenital, polymiositis, Strumpfel, fridrig ataxia, Rett syndrome, Lou Gehrig’s syndrome,etc. The demands increase on daily basis because more and more patients and families are informed about the associations and the Ministry’s programme. We must all work together in order to achieve better quality of life for the families facing such complex diseases. Everyone deserves a chance for the best possible life without marginalization and discrimination.

We still receive demands from patients who have not received treatment yet; and we are in touch with doctors asking them what needs to be done in this field so that everyone gets the necessary therapy. Unfortunately, there is not treatment for all the diseases, there are many rare diseases, around 6000 registered worldwide and for only 250 of them there is some sort of treatment. It is necessary to develop additional social services to help the families facing a rare disease for which there is no treatment available; for some on the other hand there is the need for orthopedic devices, bandages and plasters, special nutrition, additional physical therapy. FZOM works on meeting our needs and we know that as a state and as people we can do so much more. Also attention should be paid to the rare forms of cancer which at present are not included in the rare disease programme nor in FZOM. Cancer is something against which we all must fight and therefore Life with Challenges has joined the Alliance of Patient Organizations whose aim is providing better quality of life of patients with malign diseases and cancer. We hope that we can achieve some common solutions together with the institutions in order to improve this field in the health care and in the prevention as well as in treatment with available medicines and palliative care.

The New Programme of the Ministry of Health for 2016

1. Diseases which can be treated with medicines;

2. Diseases which are rare, but for which there is no treatment but which are important for the diagnostic and planning.

In the registry of patients with rare diseases are included solely the diseases listed in the ORPHAN list of rare disease – reviewed in July 2014

http://www.orpha.net/orphacom/cahiers/docs/GB/List_of_rare_diseases_in_alphabetical_order.pdf
In the Registry of rare disease patients are only included diseases which affect one in 2000 persons, but which do not exceed 20 affected at the level of Republic of Macedonia
Medicines are provided or the patients who are registered in the Registry of rare diseases through this programme. The provided medicines are necessary for the patients and represent an only choice of treatment of the rare disease, and they are not on the positive list of medicines

For the realization of this programme, treatment of rare diseases with therapy and medicines which have not been previously applied in rare disease treatment, for the provision of the necessary equipment for diagnosis of rare diseases, providing education for the staff who diagnoses and treats the rare disease patients, it is expected that in 2016 total funds in the amount of 203.000.000,00 denars will be needed.

  • Treatment of patients with a rare disease regardless of insurance status 197.000.000.00
  • Providing the necessary equipment for diagnosis and treatment of rare diseases 4.000.000.00
  • Providing education of the staff who diagnoses/treats the rare disease patients 2.000.000.00

 10398691_1018982791508396_5433419662716560523_n

За дополнителни информации слободно контактирајте нè.

For additionl information please contact us:

Contact: retkibolesti@gmail.com

 

Anja Bosilkova-Antovska

Vice President of NARDM

Tel: 070 258 049

Е-mail: anja.bosilkova@gmail.com

Vesna Aleksovska

President of NARDM

Tel: 070 705 446

Е-mail: vesna.stojmirova@gmail.com

 

 

The overall event is supported by:

CIVICA Mobilitas, Genzyme-Sanoffi Aventis, Celgene International and Skopje City Mall

Information on the Association

The National Alliance of Rare Diseases in Macedonia has existed for over two years and it actively works on improving the quality of life of patients and their families facing a rare disease. The Alliance together with its 13 member organizations presently covers more than 50 different rare diseases in Macedonia and we hope that other rare disease advocacy organizations will join us. Together we advocate for treatment, care and services which we need and we create solutions for the daily challenges that accompany rare diseases, for example the National Plan for rare diseases with which the treatment of rare diseases will be institutionalized and a long-term solution will be provided for the patient and their families’ problems. Our activities have the aim to raise public and institutional awareness, education, counseling, and support to families, education of doctors, nurses, activation and education of volunteers and cooperation with international organizations.

www.facebook.com/NARBMakedonija
retkibolesti@gmail.com


Exhibition – Lysosomal storage diseases – International Gaucher Day

On 24.09.2015 at Kinoteka – Macedonia, we opened the First travelling regional exhibition of photos with subject – lysosomal storage diseases. This exhibition shows life of patients and their families from Croatia, Serbia, Macedonia and Bosnia and Herzegovina. Lysosomal storage diseases are group of rare diseases that is consisted from more than 45 hereditary metabolic diseases. 

Покана за изложба ЛБН

This project is realized in the frames of the PAL award program (Patient Advocacy Leadership Award), where Genzyme Sanofi Aventis is supporting innovative projects of patient organizations.

plakat

With this event, the Association of citizens for rare diseases Life With Challenges is also marking the International Gaucher Day (1st October). This day is marked in more than 40 countries, where member organizations of the European Gaucher Alliance, realize events for patients, families, doctors, researchers …

IGD alb posterIGD mk poster

From Gaucher Diseases, in Macedonia there are 8 patients. The disease is manifested in 3 types, but in Macedonia only Type 1 is present, and the symptoms are spleen and liver enlargement, fragile bones, thrombocytopenia, low hemoglobin levels etc … Until this year, 5 patients were treated on donation program by Genzyme Sanofi Aventis, and 1 through the Program for Rare diseases of the Ministry of Health in Macedonia. From this month, all patients have therapy provided by the Ministry of health. This therapy exists in the world since 1991. With this therapy all symptoms that occur in the years before treatment slowly disappear and the patients can have normal life.

As a Gaucher patient my self, I am thankful for the progress in treatment of patients with Gaucher Diseases in Macedonia. From my diagnosis 23 years ago, I am happy that from now on, the patients will not have to wait so long to be treated and they do not have to be afraid for their future. With early diagnosis, early treatment will now be possible in Macedonia. And with that these patients can lead normal lives as all the other citizens in R. Macedonia. I hope that all patients with rare diseases and other diseases in Macedonia will get the chance to have healthy life. – Vesna Aleksovska, president of Life With Challenges 

DSC_3079

From MPS 2 – Hunter Syndrome, there are 2 patients in Macedonia for whom therapy is provided through the Program for Rare diseases at the Ministry of Health since 2009.

From MPS 4 – Morqio Syndrome, there are 2 patients in Macedonia, and their therapy will be provided by the Ministry until the end of this year.

DSC_3110

About rare diseases

According to definition, rare diseases are those that occur to less than 5 people in population of 10 000. Although they are rare on their own, together as a group there are 6-7 000 rare diseases in the world and in the EU, 20-30 million people are affected by a rare disease.

Rare diseases are different between each other but the patients and their families face similar difficulties that occur from the rarity of the disease. The problems are many, from diagnosis, to treatment access and social exclusion …

Despite all, the strength, the optimism, and the hope for better tomorrow are the main weapon for the patients and their families in the fight for longer life with better quality. It is to all of us to support them and make their life easier …

DSC_3099

 


Climbing Golem Korab, 2015

The Association of citizens for rare diseases LIFE WITH CHALLENGES is continuing the tradition of climbing the highest mountain top in Macedonia – Golem Korab in 2015.

For 8th of September, the Independence day of R. Macedonia, traditionally the Association Korab  organized the Climbing of Golem Kkorab, the highest mountain top in Macedonia. The flag of Life With Challenges was on the top together with the flag of Korab. 

DSC01681

This activity is for raising public awareness about rare diseases in Macedonia and about the challenges that families face in their every day life, living with a rare disease. We are thankful to the president of Korab, Ljubomir Kotevski, that supported this idea with an open heart.

Through the program for rare diseases at the Ministry of Health, 21 medicines for rare diseases are already being supplied: Wilson Diseases, Gaucher Diseases, Tyrosinemia, Juvenile Arthritis, Hereditary Angioedema, Tuberous Sclerosis, PKU, ALS, Factor 13, Pulmonary Hypertension and we expect medicines for MPS 4 also. For MPS 2 medicines are already supplied in the past 5 years.  We also expect this program to become bigger and to get more medicines for other rare diseases. The registry of patients with rare diseases is being developed and with registration of new patients, new medicines should be supplied. We should not forget that medicines are not the only thing needed for better quality of life. Many patients need orthopedic devices, special food and many social services. We are thankful that the Ministry of Health started resolving the problems of families with rare diseases and we hope that further steps will follow from the institutions to support better quality of life of patients with rare diseases. – Vesna Aleksovska, President of Life With Challenges. 

At this moment, Life With Challenges is conducting research on rare diseases in cooperation with Studiorum and with support of other organizations and institutions. The goal is to pin point the policies and practices in the field of rare diseases in Macedonia and the quality of life of the patients. The results of this research together with recommendations will be promoted on Rare Disease Day, 2016.

As an association we hope that our continuous educational activities and activities for raising public awareness will contribute towards finding new ways to better support and help families that face rare diseases and cooperate with institutions to overcome the challenges.

DSC01671


Page 8 of 13First...789...Last

News

Contact us

Sending your message...